Pfizer Ceo Net Worth (Updated 2026).

Albert Bourla, the current CEO of Pfizer, began his career in the pharmaceutical industry in 1993. He started as a quality control chemist at a Pfizer plant in Greece, his home country. This entry-level position marked the beginning of a journey that would see him rise through the ranks to become the company’s top executive.

Bourla’s rise to fame in the pharmaceutical world was gradual yet steady. He earned his Ph.D. in Veterinary Medicine from the Aristotle University of Thessaloniki in Greece before joining Pfizer. His strong scientific background, coupled with his dedication and hard work, helped him stand out and climb the corporate ladder. He held various roles, including senior vice president of Pfizer’s Animal Health division, before being appointed as the company’s CEO in 2019.

Pfizer CEO’s Current Net Worth (2025)

As of 2025, Pfizer’s CEO, Albert Bourla, has an estimated net worth of $25 million, according to Forbes. This figure reflects his compensation and stock holdings since taking over as CEO in 2019.

Career

Albert Bourla began his career at Pfizer in 1993, working his way up from an entry-level position to become CEO in 2019. He previously served as the company’s Chief Operating Officer and headed its vaccines business. Bourla is known for leading Pfizer’s COVID-19 vaccine development and distribution efforts.

Other Ventures

Bourla’s compensation package includes Pfizer stock, which has increased in value due to the company’s success with its COVID-19 vaccine. He also serves on the board of directors for the PhRMA, the main trade group for the U.S. pharmaceutical industry.

Assets

Bourla’s assets include a significant stake in Pfizer, valued at around $15 million in 2025. He also owns several properties, including a home in New York valued at over $3 million. His total assets are estimated to be around $30 million.

Annual Income

In 2020, Bourla’s total compensation at Pfizer was $17.5 million, which included a base salary of $2.5 million, a cash bonus of $6.5 million, and stock awards valued at $8.5 million. His annual income has since increased due to the company’s success with its COVID-19 vaccine.

Frequently Asked Questions about  Pfizer Ceo

**Frequently Asked Questions: Pfizer CEO Net Worth**

Q1: Who is the current CEO of Pfizer?

The current CEO of Pfizer is Albert Bourla.

Q2: How long has Albert Bourla been the CEO of Pfizer?

Albert Bourla became the CEO of Pfizer in 2019.

Q3: What was Albert Bourla’s role at Pfizer before becoming CEO?

Before becoming CEO, Albert Bourla served as the Chief Operating Officer and President of Pfizer.

Q4: What is Albert Bourla’s net worth?

Albert Bourla’s net worth is estimated to be around $100 million.

Q5: How does Albert Bourla’s net worth compare to other pharmaceutical CEOs?

Albert Bourla’s net worth is similar to that of other major pharmaceutical CEOs. For instance, the net worth of the CEO of Merck, Kenneth Frazier, is also estimated to be around $100 million.

Q6: How has Pfizer’s stock performed under Albert Bourla’s leadership?

Since Albert Bourla took over as CEO, Pfizer’s stock has increased significantly. As of 2021, it has more than doubled from its value in 2019.

Q7: What is Albert Bourla’s educational background?

Albert Bourla holds a veterinary degree from the Veterinary School of Aristotle University of Thessaloniki, Greece, and an MBA from the Warrington College of Business at the University of Florida.

Q8: What are some of the key initiatives Albert Bourla has led at Pfizer?

Under Albert Bourla’s leadership, Pfizer has made significant strides in its COVID-19 vaccine development, as well as in its efforts to advance its pipeline of innovative medicines and therapies.

Q9: How does Albert Bourla’s compensation compare to other CEOs in the pharmaceutical industry?

Albert Bourla’s compensation is in line with other CEOs in the pharmaceutical industry. In 2020, his total compensation was around $21 million, which includes his salary, stock awards, and other forms of compensation.

Q10: What is Albert Bourla’s approach to innovation and drug discovery at Pfizer?

Albert Bourla has emphasized the importance of innovation and scientific breakthroughs at Pfizer. He has led the company to focus on areas such as rare diseases, immunology, and inflammation, among others, to develop new and effective treatments.